or Try an Advanced Search...

    Regulus Therapeutics Stocks List

    Symbol Grade Name % Change
    LPTX B LEAP THERAPEUTICS, INC. -0.61
    RGLS B Regulus Therapeutics Inc. 0.00
    SPRO D Spero Therapeutics, Inc. 0.42
    CAPR D Capricor Therapeutics, Inc. -0.60
    PRQR D ProQR Therapeutics B.V. -3.16
    ABOS F Acumen Pharmaceuticals, Inc. -2.52
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Alnylam Pharmaceuticals Biotechnology Oligonucleotide Alzheimer's Disease Amyloid Amyloid Beta Amyloidosis Antimicrobial Resistance Atherosclerosis Bacterial Infections Biology Blastoma Cancer Carcinoma Cardiovascular Disease Cystic Fibrosis Disease Drug Resistant Bacterial Infections Evolutionary Biology

    Related ETFs - A few ETFs which own one or more of the above listed Regulus Therapeutics stocks.

    Symbol Grade Name Weight
    IBRN D iShares Neuroscience and Healthcare ETF 0.64
    CSML C IQ Chaikin U.S. Small Cap ETF 0.19
    IWC C iShares Microcap ETF 0.08
    AVSC C Avantis U.S. Small Cap Equity ETF 0.01
    DFAS C Dimensional U.S. Small Cap ETF 0.0
    View all Regulus Therapeutics ETFs...
    Compare ETFs
    Compare CSML to IWC Compare IBRN to IWC Compare IWC to AVSC

        Regulus Therapeutics Stocks Recent News

        Date Stock Title
        Apr 24 CAPR Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation
        Apr 24 CAPR Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
        Apr 23 SPRO Spero Therapeutics Delivers On Game Plan To Create Shareholder Value
        Apr 23 PRQR ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
        Apr 22 PRQR ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
        Apr 19 ABOS 12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By
        Apr 19 PRQR ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Alnylam Pharmaceuticals Biotechnology Oligonucleotide Alzheimer's Disease Amyloid Amyloid Beta Amyloidosis Antimicrobial Resistance Atherosclerosis Bacterial Infections Biology Blastoma Cancer Carcinoma Cardiovascular Disease Cystic Fibrosis Disease Drug Resistant Bacterial Infections Evolutionary Biology
        Regulus Therapeutics

        Regulus Therapeutics Inc. or Regulus (NASDAQ: RGLS) is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.

        More about Regulus Therapeutics
        Browse All Tags